Benzinga | Oct 19, 2020 08:21AM EDT

Deutsche Bank Downgrades Mednax to Sell, Lowers Price Target to $12

Deutsche Bank analyst Pito Chickering downgrades Mednax (NYSE:MD) from Hold to Sell and lowers the price target from $20 to $12.